Medline, Inc. (MDLN)
34.70
+0.44
(+1.28%)
USD |
NASDAQ |
Aug 24, 16:00
34.70
0.00 (0.00%)
After-Hours: 20:00
Medline Enterprise Value : 47.90B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 47.90B |
| August 21, 2026 | 47.51B |
| August 20, 2026 | 46.04B |
| August 19, 2026 | 47.21B |
| August 18, 2026 | 47.39B |
| August 17, 2026 | 48.06B |
| August 14, 2026 | 48.81B |
| August 13, 2026 | 48.67B |
| August 12, 2026 | 48.60B |
| August 11, 2026 | 48.20B |
| August 10, 2026 | 47.12B |
| August 07, 2026 | 48.36B |
| August 06, 2026 | 47.73B |
| August 05, 2026 | 49.62B |
| August 04, 2026 | 54.34B |
| August 03, 2026 | 52.96B |
| July 31, 2026 | 51.91B |
| July 30, 2026 | 51.77B |
| July 29, 2026 | 52.62B |
| July 28, 2026 | 52.99B |
| July 27, 2026 | 52.28B |
| July 24, 2026 | 51.45B |
| July 23, 2026 | 50.47B |
| July 22, 2026 | 50.07B |
| July 21, 2026 | 51.75B |
| Date | Value |
|---|---|
| July 20, 2026 | 51.56B |
| July 17, 2026 | 52.36B |
| July 16, 2026 | 53.52B |
| July 15, 2026 | 52.05B |
| July 14, 2026 | 51.37B |
| July 13, 2026 | 53.05B |
| July 10, 2026 | 53.46B |
| July 09, 2026 | 53.29B |
| July 08, 2026 | 52.81B |
| July 07, 2026 | 55.19B |
| July 06, 2026 | 54.96B |
| July 02, 2026 | 55.34B |
| July 01, 2026 | 54.06B |
| June 30, 2026 | 52.05B |
| June 29, 2026 | 51.99B |
| June 26, 2026 | 51.36B |
| June 25, 2026 | 50.43B |
| June 24, 2026 | 48.97B |
| June 23, 2026 | 48.34B |
| June 22, 2026 | 47.84B |
| June 18, 2026 | 48.88B |
| June 17, 2026 | 49.29B |
| June 16, 2026 | 49.85B |
| June 15, 2026 | 50.06B |
| June 12, 2026 | 49.45B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ICU Medical, Inc. | 5.554B |
| Insulet Corp. | 10.50B |
| Abbott Laboratories | 229.54B |
| AngioDynamics, Inc. | 614.71M |
| Alphatec Holdings, Inc. | 1.920B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 139.00M |
| Revenue (Quarterly) | 7.685B |
| Total Expenses (Quarterly) | 7.625B |
| EPS Diluted (Quarterly) | 0.0697 |
| Gross Profit Margin (Quarterly) | 26.52% |
| Profit Margin (Quarterly) | 1.81% |
| Earnings Yield | 2.46% |
| Operating Earnings Yield | 6.81% |
| Normalized Earnings Yield | 3.876 |